Apixaban Dosing for Left Ventricular Thrombus
Dosing Recommendations
- The American College of Cardiology recommends an initial treatment dose of apixaban at 10 mg orally twice daily for the first 7 days, followed by 5 mg orally twice daily for left ventricular thrombus treatment, which is appropriate as it follows the same anticoagulation principles used for treating thrombotic conditions 1, 2
- After 6 months of initial therapy, either continuing with 5 mg twice daily or reducing to 2.5 mg twice daily can be considered for extended treatment, according to the American College of Cardiology 2, 3
Dose Adjustments
- The American College of Cardiology recommends dose reduction to 2.5 mg twice daily if the patient meets at least 2 of the following 3 criteria: age ≥80 years, body weight ≤60 kg, or serum creatinine ≥1.5 mg/dL 4, 5
- For patients with severe renal impairment, apixaban should be used with caution, as these patients were excluded from clinical trials, as stated by the National Comprehensive Cancer Network 6, 7
Safety Considerations
- Apixaban has demonstrated a favorable bleeding profile compared to warfarin in clinical trials, with fewer major bleeding events, according to the American Heart Association, as published in Stroke 8
Common Pitfalls and Caveats
- The American College of Cardiology advises not to confuse the dosing for atrial fibrillation with the initial VTE treatment dosing, and to ensure proper assessment of renal function before initiating therapy, as dose adjustments are needed for patients with significant renal impairment 1, 4, 6, 7
- The American College of Cardiology also recommends monitoring for drug interactions, particularly with strong dual inhibitors of CYP3A4 and P-glycoprotein, which may require dose adjustment 4